Get the app
NSEHealthcare

Brooks Laboratories Limited (BROOKS)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹61.23+0.34%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
₹23 cr
Revenue YoY
-10.0%
Net profit
₹-2 cr
Profit YoY
-118.6%
EPS
₹0.94
EPS estimate
₹1.02
Net margin
-7.8%

EPS came in at 0.94 against a street estimate of 1.02 — a miss of 7.8%.

Key statistics

Market cap
₹194 cr
P/E
14.6
Forward P/E
0.0
P/B
1.58
Book value
₹41.64
EPS (TTM)
₹4.49
52-week high
₹163.90
52-week low
₹36.30
50-day MA
₹64.62
200-day MA
₹66.88
Beta
1.09

Analyst view

with an average price target of ₹53.00.

Shareholding

Promoters
55.88%
Institutions
9.90%

Recent filings & reports

DocumentDate
Annual report FY2026
BROOKS LABORATORIES LIMITED — ANNUAL REPORT 2025-26 SUMMARY HEADLINE NUMBERS • Revenue from operations: Rs. 8,573.84 lakhs (FY 2025-26) vs Rs. 8,255
2026-08-21
Quarterly results · Q1 FY27
BROOKS LABORATORIES LIMITED – Q1 FY2027 FINANCIAL SUMMARY HEADLINE NUMBERS • Standalone Revenue from Operations (Q1 FY27): Rs. 2,296.08 lakhs vs Rs.
2026-08-13
Annual report FY2026
BROOKS LABORATORIES LIMITED – ANNUAL REPORT 2025-26 SUMMARY HEADLINE NUMBERS • Revenue from operations: Rs. 8,573.84 lakhs (FY 2025-26) vs Rs. 8,255
2026-08-12
Quarterly results · Q4 FY26
BROOKS LABORATORIES LIMITED – FINANCIAL SUMMARY Board Meeting Outcome, 29th May 2026 --- HEADLINE NUMBERS • FY 2025-26 Revenue from Operations (Sta
2026-05-29
Quarterly results · Q3 FY26
BROOKS LABORATORIES LIMITED – FINANCIAL RESULTS SUMMARY Quarter & Nine Months Ended 31 December 2025 --- HEADLINE NUMBERS STANDALONE (Company Only)
2026-02-06
Quarterly results · Q2 FY26
BROOKS LABORATORIES LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Quarter ended Sept 30, 2025 (Standalone): Revenue Rs 2,345.07 Lakhs | Net Profit
2025-11-14
Annual report FY2025
BROOKS LABORATORIES LIMITED - ANNUAL REPORT 2024-25 SUMMARY --- HEADLINE NUMBERS • Total Revenue from Operations: Rs. 8,255.68 lakhs (FY 2024-25) v
2025-09-04
Quarterly results · Q1 FY26
BROOKS LABORATORIES LIMITED – Q1 FY2025-26 FINANCIAL SUMMARY HEADLINE NUMBERS • Standalone Revenue from Operations (Q1): Rs. 2,551.19 Lakhs (vs. Rs.
2025-08-13

Readable in the app.

Deals & corporate news

AnnouncementDate
Merger of associate Brooks Steriscience Limited through scheme of arrangement
Brooks Laboratories Limited announced the merger of Brooks Steriscience Limited (BSL), which is a joint venture/associate company, through a Composite Scheme of Arrangement and Amalgamation.
2025-09-26

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Brooks Laboratories Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.